Work

Tolerability and efficacy of sodium–glucose co‐transporter‐2 inhibitors in Australian Aboriginal and Torres Strait Islanders with type 2 diabetes mellitus: an observational study

Year: 2023

Type: article

Abstract: Sodium-glucose co-transporter-2 inhibitors (SGLT2i) have renal and cardiovascular benefits in addition to their glucose-lowering potential. Data on the efficacy and safety of SGLT2i in Australian Aboriginal and Torres-Strait Islanders are lacking. We conducted a single-centre retrospective study assessing the safety and effects on glycaemic control and albuminuria of SGLT2i in Aboriginal and Torres Strait Islander patients with type 2 diabetes mellitus.

Source: Internal Medicine Journal

DOI: 10.1111/imj.16245

Authors: Noor Fishan, Kurt Towers, Javier Haurat, Anthony Zimmermann, Anjana Radhakutty

Institutions: Government of South Australia, SA Health, The Royal Melbourne Hospital, Flinders University

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,240